- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02714699
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
January 4, 2018 updated by: Ahmed Mohamed Abbas, Assiut University
Randomized Clinical Trial of Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium in Reducing Pain During Office Hysteroscopy
The study aims to determine the efficacy of oral hyoscine butyl bromide versus diclofenac potassium on the pain scores during office hysteroscopy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
129
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo
-
Assiut, Cairo, Egypt, 002
- Ahmed Abbas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients that must perform a diagnostic hysteroscopy.
- Acceptance to participate in the study.
- Signed informed consent.
- Not taking analgesics (acetaminophen, ibuprofen, mefenamic acid) before admission.
- Absence of sedative use before admission
Exclusion Criteria:
- Hypersensitivity to drugs
- refusal of the patient
- Patients are pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: diclofenac potassium
oral diclofenac potassium
|
patients will take oral diclofenac potassium; two tablets (cataflam 25 mg) and one tablet placebo one hour before the procedure
Other Names:
|
|
ACTIVE_COMPARATOR: hyoscine butyl bromide
oral hyoscine butyl bromide
|
patients will take oral hyoscine-N- butyl bromide; 2 tablets (buscopan 10 mg) one hour before the procedure
Other Names:
|
|
PLACEBO_COMPARATOR: placebo
oral placebo
|
patients will take oral placebo; 2 tablets one hour before the procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean pain score during hysteroscopy
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2016
Primary Completion (ACTUAL)
March 1, 2017
Study Completion (ACTUAL)
May 1, 2017
Study Registration Dates
First Submitted
March 16, 2016
First Submitted That Met QC Criteria
March 18, 2016
First Posted (ESTIMATE)
March 21, 2016
Study Record Updates
Last Update Posted (ACTUAL)
January 5, 2018
Last Update Submitted That Met QC Criteria
January 4, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Parasympatholytics
- Autonomic Agents
- Peripheral Nervous System Agents
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antiemetics
- Gastrointestinal Agents
- Adjuvants, Anesthesia
- Anticonvulsants
- Mydriatics
- Diclofenac
- Bromides
- Scopolamine
- Butylscopolammonium Bromide
Other Study ID Numbers
- HB-OH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopy
-
Buddhist Tzu Chi General HospitalUnknownMethods of Nasal Anesthesia Before Transnasal Endoscopy | Side Effects of Transnasal Endoscopy | Patient's Tolerance to Transnasal EndoscopyTaiwan
-
Fujifilm Medical Systems USA, Inc.Completed
-
Children's Mercy Hospital Kansas CityCompletedEndoscopyUnited States
-
State University of New York - Upstate Medical...Completed
-
Tabriz UniversityCompleted
-
University of NebraskaChildren's Hospital and Medical Center, Omaha, NebraskaCompleted
-
University Hospital, GhentRecruiting
-
Gaziosmanpasa Research and Education HospitalRecruiting
Clinical Trials on diclofenac potassium
-
Hospital Universitario de CaracasCompletedPediatric Anesthesia | Tonsillectomy | Post Operative AnalgesiaVenezuela
-
Aswan University HospitalCompletedInfertility, FemaleEgypt
-
Novartis PharmaceuticalsCompleted
-
Cairo UniversityUnknown
-
Humanis Saglık Anonim SirketiCompletedBioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated TabletAnalgesic | Non-steroidal Anti-inflammatory (NSAID) | AntipyreticJordan
-
Danish Headache CenterTerminatedMigraine Without Aura | Migraine With AuraDenmark
-
CMH Multan Institute of Medical SciencesCompletedPostoperative Pain | Cesarean Section Pain | Diclofenac | SuppositoryPakistan
-
DepomedCompleted
-
Javelin PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated